Editas Medicine Aktie
WKN DE: A2AC4K / ISIN: US28106W1036
|
05.03.2025 22:50:03
|
EDITAS MEDICINE, INC. Q4 Loss Increases, Misses Estimates
(RTTNews) - EDITAS MEDICINE, INC. (EDIT) revealed Loss for its fourth quarter that increased from the same period last year and missed the Street estimates.
The company's earnings came in at -$45.40 million, or -$0.55 per share. This compares with -$18.87 million, or -$0.23 per share, last year.
Analysts on average had expected the company to earn -$0.33 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period fell 49.0% to $30.60 million from $60.05 million last year.
EDITAS MEDICINE, INC. earnings at a glance (GAAP) :
-Earnings: -$45.40 Mln. vs. -$18.87 Mln. last year. -EPS: -$0.55 vs. -$0.23 last year. -Revenue: $30.60 Mln vs. $60.05 Mln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Editas Medicine Incmehr Nachrichten
|
11.05.25 |
Ausblick: Editas Medicine verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) |
Analysen zu Editas Medicine Incmehr Analysen
Aktien in diesem Artikel
| Editas Medicine Inc | 3,07 | -0,55% |
|